Alcor Clinical Outsourcing Platform 20th and 21st September Boston USA


Alcor Clinical Outsourcing Platform 18th and 19th October Prague, Czech Republic


Alcor Clinical Outsourcing Platform 2023 intends to focus on global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration and strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing, and financial planning, as well as innovative sessions on new technologies The Alcor Clinical outsourcing Platform 2023 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. A broad range of people from the clinical trials community from around the world are participating in this multidisciplinary program to gain a deeper understanding of clinical research and clinical trials management.
During the last two decades, Pharma and Biotechnology companies have been constantly evolving, with new clinical studies, technologies, and advances in care and treatment enhancing efficiency while increasing the complexity of clinical trials, which require highly structured and coordinated testing. To address these issues, we need to look into innovative strategies, effective and quality collaborations, and new technologies that can cater to both patients’ and industry needs.

Why Attend

Create Your Roadmap

Maximize Your Network

Industry Knowledge

Make New Business contacts

Expect to make sales as a result

Exhibitors pleased with the quality of visitors

All Visitors looks for new business partners

Find Innovative solutions from industry thought leaders

Our Speakers

Ekatherina Goryachikov

VP and Head of Clinical Operations, Adicet Bio

Oscar Segurado

Chief Medical Officer, ASC Therapeutics

Bao Dinh

Associate Director, Clinical Data Management, Ascendis Pharma

Luis A. Aguilar

VP, Business and Clinical Operations, Candel Therapeutics

Joe Coffie

Sr. Clinical Operations Professional, Imago BioSciences

Darshita N Patel

Director, Clinical Operations, Iovance Therapeutics

Joe Shan

Executive Director, Clinical Development Operations, MEI Pharma

Farah Anwar

Senior Vice President, Head of Development Operations and Inclusion, Diversity and Equity, Sana Biotechnology

Dorothy Nguyen

Vice President of Clinical Development, AmMax Bio

Gary Albert

Director, Clinical Operations, Patient Recruitment and Trial Management, Formerly Turning Point Therapeutics

Joan Chambers

Senior Director, CISCRP

Allyson Gunsallus

Associate Director, BridgeBio


President, BioKier,

Behtash Bahador

Director, Health Literacy, CISCRP

Michael Hickey

Director, Clinical Program Management , Bio-Path Holdings

Om Dhingra

Vice-Chair And Co-Founder, Marius Pharmaceuticals


Vice President, Head of Clinical Operations, Spring Works Therapeutics

Jamie Kime

Vice President, Clinical Operations & Procurement, Locus Biosciences

Barb Geiger

Sr VP Clinical Operations, Mana Therapeutics

Charlene Knape

Vice President, Clinical Affairs, NecteroMedical Inc

ABAC Therapeutics

David Dworaczyk

CEO, Bryn Pharma

DeAnn Hyder

Associate Director, Clinical Data Management And Programming, Kronos Bio

Deborah Covington

Global Director Clinical Outsources Management, Grifols

Jennifer Cook

Clinical Research Patient Engagement, DCRI

ABAC Therapeutics

Ed Addison

Co Founder, Cloud Pharmaceuticals

Matthew Barnes

Director Portfolio Management, Virpax Pharmaceuticals

Michael Karg

Sr. Director, Clinical Operations, Precision Biosciences

Bruce Morimoto

Vice President, Drug Development, Alto Neuroscience

Meraf Eyassu

Executive Director, Clinical Operations, Terns Pharmaceuticals

Meghan McKenzie

M.A. Patient Inclusion and Health Equity, Chief Diversity Office, Genentech

Esther Marfo

Project Leader, Health Equity And Population Sciences, Hoffman La Roche

Abby Kennedy

VP of Clinical Operations, CymaBay Therapeutics, Inc

Isabel Brown

Inclusive Research and Health Equity - gRED ECD Clinical Operations,Genentech

Jasmina Jankicevic

Consulting Dermatologist, Clinical Development & Medical Affairs RAPT Therapeutics, Inc.

Liza Melchor-Khan

Sr. Director, Clinical Operations NGM Bio

Vineeta Gulati

Director, Clinical Operations GSID

Sandy Mohan

Vice President, Quality Iovance Biotherapeutics

Peter B. Heifetz

President and CEO OrPro Therapeutics

Kumar Gadamasetti

Chief Executive Officer Certum Bio

Irene Szeto

Executive Director, Global Digital Quality Management Systems and Business Intelligence BeiGene

Wendi Carroll

Executive Director, Global Medical Affairs Study Management, BioMarin Pharmaceuticals, Inc

Dr Chris Apfel

CEO, SageMedic Corp

Kunal Sampat

Host, Clinical Trial Podcast

Sarah Mullen

Vice President Of Clinical, HeartFlow

Arun Sivanandam

Associate Director, Clinical Operations, Santen

Sharon Horton

Vice President, Program Management, Iovance Biotherapeutics

Dr Lian Cunningham

Vice President Of Clinical Affairs, Endogenex

Emmett ‘Alton’ Sartor

Medical Director, Patient Safety Physician Digital & Devices, AstraZeneca

Lisa Sergas

Executive Director, Clinical Outsourcing and Alliance Management, BridgeBio Pharma, Inc.

Solutions at ACOP 2023

  • Bio Statistics
  • Central Laboratory Services
  • Clinical Data Management
  • Clinical Monitoring
  • Clinical Operations
  • Clinical Program Management
  • Clinical Research
  • Clinical Trial Management
  • Drug Procurement Services
  • Contract Research Organization
  • Development Operations
  • Device testing
  • eClinical Technologies
  • Electronic Data Capture
  • Global Clinical Research & Development
  • Global Project & site Management
  • Health Economics & Outcomes Research
  • Imaging Tools
  • Investigator Site Services
  • Logistics & Materials Handling
  • Medical Devices
  • Medical Testing
  • Medical Translation
  • Medical Writing & Simulation
  • Patient recruitment & Retention
  • Pharmacovigilance
  • Pharmacovigilance & Drug Safety
  • Quality Assurance
  • Regulatory Affairs
  • Statistical Programming

Target Audience

Audience Will Include VPs, Global Heads & Directors


08:45 – 09:00 am Chairman’s Welcome Remarks

09:00 – 09:30 am Presentation 1

09:30 – 10:00 am Presentation 2

10:00 – 10:30 am Presentation 3

08:45 – 09:00 am Chairman’s Welcome Remarks

09:00 – 09:30 am Presentation 12

09:30 – 10:00 am Presentation 13

10:00 – 10:30 am Presentation 14

Media Partners